--- title: "BINHAI TEDA Logistics: Hu Shanshan has been appointed as a non-executive director" type: "News" locale: "en" url: "https://longbridge.com/en/news/253771344.md" description: "According to the Zhitong Finance APP, BINHAI TEDA Logistics announced that (1) Ms. Sun Jing has resigned from her position as a non-executive director, effective after the board of directors approves the appointment of Ms. Hu Shanshan as the new non-executive director. (2) Ms. Hu Shanshan has been appointed as a non-executive director, effective after the relevant appointment proposal is approved at the board meeting held on August 20, 2025, and her term will only last until the next annual general meeting of shareholders, at which time Ms. Hu Shanshan will be eligible for re-election" datetime: "2025-08-20T08:52:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/253771344.md) - [en](https://longbridge.com/en/news/253771344.md) - [zh-HK](https://longbridge.com/zh-HK/news/253771344.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/253771344.md) | [繁體中文](https://longbridge.com/zh-HK/news/253771344.md) # BINHAI TEDA Logistics: Hu Shanshan has been appointed as a non-executive director According to the announcement from Binhai Teda Logistics (08348), (1) Ms. Sun Jing has resigned from her position as a non-executive director, effective after the board's approval of the appointment of Ms. Hu Shanshan as the new non-executive director. (2) Ms. Hu Shanshan has been appointed as a non-executive director, effective after the relevant appointment proposal is approved at the board meeting held on August 20, 2025, and her term will only last until the next annual general meeting of shareholders, at which time Ms. Hu Shanshan will be eligible for re-election ### Related Stocks - [BINHAI TEDA (08348.HK)](https://longbridge.com/en/quote/08348.HK.md) ## Related News & Research - [China's detentions of Panama-flagged vessels raise concerns, Rubio says](https://longbridge.com/en/news/281541796.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md) - [Shin Hwa World logs FY revenue HK$966.9 mln](https://longbridge.com/en/news/281055310.md) - [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/en/news/281223382.md) - [08:33 ETInc. Names Interstate to Its 'Fastest-Growing in the Mid-Atlantic' List](https://longbridge.com/en/news/281524757.md)